课题基金 / 基金详情

Advanced Development of Antibacterial Countermeasures

Advanced Development of Antibacterial Countermeasures
抗菌对策的先进发展
批准号：
10787969
负责人：
TROY LISTER
金额：
$149.46万
依托单位：
SPERO THERAPEUTICS, INC.
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
未结题
起止时间：
2021-05-17 至 2025-04-25
来源：
https://reporter.nih.gov/project-details/10787969
关键词：
AddressAdvanced DevelopmentAnti-Bacterial AgentsAntibiotic ResistanceChemistryClinicalDevelopmentGram-Negative BacteriaPathway interactionsbacterial resistanceefficacy evaluationmanufacturenovel therapeuticsphase I trialpre-clinicalproduct developmentresearch and developmentresearch clinical testingsafety assessmenttherapeutic candidate

项目摘要

项目成果

TROY LISTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of a promising candidate therapeutic for antibacterial resistance, including biodefense pathogens. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advanced Development of Antibacterial Countermeasures
  • 批准号：
    10410065
  • 项目类别：
  • 资助金额：
    $208.98万
  • 财政年份：
    2021
  • 负责人：
    TROY LISTER
  • 依托单位：
    SPERO THERAPEUTICS, INC.
海外基金